JPMORGAN CHASE & CO

Position in CATX — Perspective Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in CATX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$160,739

+$38,806 QoQ

Shares Held

47,138

+61.2% QoQ

Ownership

0.041%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#60

of 130 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 9% Shared 0% None 91%

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $14,280,904,557 across 102 Medical Devices names. CATX ranks #66 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SYK	Stryker Corp	17,260,943	$5,434,435,284
2	MDT	Medtronic plc	27,784,471	$2,173,579,157
3	EW	Edwards Lifesciences Corp	22,783,175	$2,060,966,003
4	ABT	Abbott Laboratories	15,095,898	$1,369,801,775
5	BSX	Boston Scientific Corp	23,907,838	$1,020,386,517
6	GEHC	GE HealthCare Technologies Inc.	10,329,164	$661,169,779
7	PEN	Penumbra Inc	1,071,454	$338,311,597
8	DXCM	Dexcom Inc	3,325,095	$223,945,140

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$160,739	47,138	+61.2%	Shares	Defined	2026-08-12
2026-03-31	$121,933	29,241	+4.3%	Shares	Defined	2026-05-13
2025-12-31	$77,092	28,034	-93.6%	Shares	Defined	2026-02-11
2025-09-30	$1,496,703	436,357	-41.7%	Shares	Defined	2025-11-07
2025-06-30	$2,573,349	748,067	+118.4%	Shares	Defined	2025-08-12
2025-03-31	$729,428	342,455	+129.8%	Shares	Defined	2025-05-12
2024-12-31	$475,452	149,045	+498.3%	Shares	Defined	2025-02-12
2024-09-30	$332,575	24,912	+24.1%	Shares	Defined	2024-12-26
2024-06-30	$200,077	20,068	-99.2%	Shares	Defined	2024-12-26
2024-03-31	$3,071,542	2,581,128	+535403.7%	Shares	Defined	2024-12-26
2023-12-31	$192	482	+46.1%	Shares	Defined	2024-12-26
2023-09-30	$89	330	—	Shares	Defined	2023-11-14
No filing history on record for this holder in this stock.